These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 16682702)

  • 1. Dispute over Vioxx study plays out in New England journal.
    Kondro W
    CMAJ; 2006 May; 174(10):1397. PubMed ID: 16682702
    [No Abstract]   [Full Text] [Related]  

  • 2. NEJM editor gives pretrial evidence in Vioxx case.
    Tanne JH
    BMJ; 2006 Feb; 332(7536):255. PubMed ID: 16455704
    [No Abstract]   [Full Text] [Related]  

  • 3. Lapses at the new England journal of medicine.
    Smith R
    J R Soc Med; 2006 Aug; 99(8):380-2. PubMed ID: 16893926
    [No Abstract]   [Full Text] [Related]  

  • 4. The sad story of Vioxx, and what we should learn from it.
    Karha J; Topol EJ
    Cleve Clin J Med; 2004 Dec; 71(12):933-4, 936, 938-9. PubMed ID: 15641522
    [No Abstract]   [Full Text] [Related]  

  • 5. Medical journal criticizes Merck over Vioxx data.
    Berenson A
    N Y Times Web; 2005 Dec; ():A1, C13. PubMed ID: 16456990
    [No Abstract]   [Full Text] [Related]  

  • 6. NEJM stands by its criticism of Vioxx study.
    Tanne JH
    BMJ; 2006 Mar; 332(7540):505. PubMed ID: 16513694
    [No Abstract]   [Full Text] [Related]  

  • 7. Merck VIOXX "warning" is questioned.
    Allen TS; Henderson JH
    Tex Med; 2005 May; 101(5):5-6. PubMed ID: 15948521
    [No Abstract]   [Full Text] [Related]  

  • 8. How the New England Journal missed warning signs on Vioxx: medical weekly waited years to report flaws in article that praised pain drug; Merck seen as "punching bag".
    Armstrong D
    Wall St J (East Ed); 2006 May; ():A1, A10. PubMed ID: 16848016
    [No Abstract]   [Full Text] [Related]  

  • 9. Journal grows suspicious of Vioxx data.
    Wadman M
    Nature; 2005 Dec; 438(7070):899. PubMed ID: 16355178
    [No Abstract]   [Full Text] [Related]  

  • 10. Merck cleared in personal injury case against Vioxx.
    Mayor S
    BMJ; 2005 Nov; 331(7525):1101. PubMed ID: 16282390
    [No Abstract]   [Full Text] [Related]  

  • 11. Rofecoxib (Vioxx) voluntarily withdrawn from market.
    Sibbald B
    CMAJ; 2004 Oct; 171(9):1027-8. PubMed ID: 15505253
    [No Abstract]   [Full Text] [Related]  

  • 12. Quebec allows Vioxx class-action suit.
    Sibbald B
    CMAJ; 2007 Jan; 176(1):20. PubMed ID: 17200378
    [No Abstract]   [Full Text] [Related]  

  • 13. Manipulating a journal article.
    N Y Times Web; 2005 Dec; ():WK11. PubMed ID: 16453395
    [No Abstract]   [Full Text] [Related]  

  • 14. The vexations of Vioxx.
    Sibbald B
    CMAJ; 2006 Feb; 174(4):444-5. PubMed ID: 16477046
    [No Abstract]   [Full Text] [Related]  

  • 15. Ten lessons to be learned from the withdrawal of Vioxx (rofecoxib).
    Carné X; Cruz N
    Eur J Epidemiol; 2005; 20(2):127-9. PubMed ID: 15792277
    [No Abstract]   [Full Text] [Related]  

  • 16. The lessons of Vioxx--drug safety and sales.
    Waxman HA
    N Engl J Med; 2005 Jun; 352(25):2576-8. PubMed ID: 15972862
    [No Abstract]   [Full Text] [Related]  

  • 17. COX-2 inhibitor use after Vioxx: careful balance or end of the rope?
    Fendrick AM
    Am J Manag Care; 2004 Nov; 10(11 Pt 1):740-1. PubMed ID: 15623263
    [No Abstract]   [Full Text] [Related]  

  • 18. Response to 'Lapses at the NEJM'.
    Drazen JM
    J R Soc Med; 2006 Oct; 99(10):485; author reply 485. PubMed ID: 17021294
    [No Abstract]   [Full Text] [Related]  

  • 19. MI risk prompts rofecoxib withdrawal.
    Thompson CA
    Am J Health Syst Pharm; 2004 Nov; 61(21):2234-6, 2238. PubMed ID: 15552625
    [No Abstract]   [Full Text] [Related]  

  • 20. Merck's actions surrounding Vioxx.
    Heinley M
    PLoS Med; 2006 Jun; 3(6):e286; author reply e285. PubMed ID: 16789808
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.